biotech / news / / CNBC
Barrière is projecting to double its 2025 revenue to reach $10 million in 2026.
Barrière is launching the first-ever lactose intolerance patch in 1,700 Walmart stores in 2026.
KEY POINTS
- The company projects doubling 2025 revenue to reach $10 million in 2026, with a $19 million valuation.
- Barrière expanded retail presence from 600 stores in Q2 2025 to over 6,000 stores by Q2 2026.
- Barrière manufactures its patches in the U.K. for stricter regulatory oversight than in the U.S.
- Its transdermal patches use ultrasmall vitamin particles and work for up to 12 hours each.
COMPANIES
Summarized by Newsio from CNBC. How we summarize →